Project Name：Abiraterone and tablets

Registration Classification：3.1

Formulations and specifications ：Tablets, 250mg 

Indications：Combination with prednisone for the treatment of excessive West after previous chemotherapy docetaxel therapy and castration therapy in patients with metastatic prostate cancer .

Original Research Company：American Johnson 

Progress ：Pharmaceutical Research in progress